Asia-Pacific Anti-Obesity Prescription Drugs Market Report 2017

Name: Asia-Pacific Anti-Obesity Prescription Drugs Market Report 2017
Brand: QYResearch
SKU: A012632AE9DEN
Price: 4000 USD
Availability: InStock

December 2017 | 105 pages | ID: A012632AE9DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the Asia-Pacific Anti-Obesity Prescription Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Anti-Obesity Prescription Drugs for these regions, from 2012 to 2022 (forecast), including

China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Anti-Obesity Prescription Drugs market competition by top manufacturers/players, with Anti-Obesity Prescription Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

VIVUS
Orexigen Therapeutics
Novo Nordisk
F Hoffmann La Roche
Arena Pharmaceuticals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals Pharmacies
Retail Pharmacies
E-commerce

If you have any special requirements, please let us know and we will offer you the report as you want.

Asia-Pacific Anti-Obesity Prescription Drugs Market Report 2017

1 ANTI-OBESITY PRESCRIPTION DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs
1.2 Classification of Anti-Obesity Prescription Drugs by Product Category
  1.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Bupropion and Naltrexone
  1.2.4 Orlistat
  1.2.5 Lorcaserin
  1.2.6 Phentermine and Topiramate
  1.2.7 Liraglutide
1.3 Asia-Pacific Anti-Obesity Prescription Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 E-commerce
1.4 Asia-Pacific Anti-Obesity Prescription Drugs Market by Region
  1.4.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Anti-Obesity Prescription Drugs (2012-2022)
  1.5.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Anti-Obesity Prescription Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Anti-Obesity Prescription Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Anti-Obesity Prescription Drugs (Volume) by Application
2.4 Asia-Pacific Anti-Obesity Prescription Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  3.1.1 China Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
3.2 China Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
3.3 China Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

4 JAPAN ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  4.1.1 Japan Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
4.2 Japan Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
4.3 Japan Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
5.2 South Korea Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
5.3 South Korea Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

6 TAIWAN ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
6.3 Taiwan Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

7 INDIA ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  7.1.1 India Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
7.2 India Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
7.3 India Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

9 AUSTRALIA ANTI-OBESITY PRESCRIPTION DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Anti-Obesity Prescription Drugs Sales and Value (2012-2017)
  9.1.1 Australia Anti-Obesity Prescription Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Anti-Obesity Prescription Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Anti-Obesity Prescription Drugs Sales Price Trend (2012-2017)
9.2 Australia Anti-Obesity Prescription Drugs Sales Volume and Market Share by Type
9.3 Australia Anti-Obesity Prescription Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 VIVUS
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 VIVUS Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Orexigen Therapeutics
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Novo Nordisk
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Novo Nordisk Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 F Hoffmann La Roche
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Arena Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview

11 ANTI-OBESITY PRESCRIPTION DRUGS MANUFACTURING COST ANALYSIS

11.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Anti-Obesity Prescription Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anti-Obesity Prescription Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Anti-Obesity Prescription Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Anti-Obesity Prescription Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Anti-Obesity Prescription Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Anti-Obesity Prescription Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Anti-Obesity Prescription Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Anti-Obesity Prescription Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Anti-Obesity Prescription Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Obesity Prescription Drugs
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Bupropion and Naltrexone Product Picture
Figure Orlistat Product Picture
Figure Lorcaserin Product Picture
Figure Phentermine and Topiramate Product Picture
Figure Liraglutide Product Picture
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Anti-Obesity Prescription Drugs by Application in 2016
Figure Hospitals Pharmacies Examples
Table Key Downstream Customer in Hospitals Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure E-commerce Examples
Table Key Downstream Customer in E-commerce
Figure Asia-Pacific Anti-Obesity Prescription Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-Obesity Prescription Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Anti-Obesity Prescription Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Anti-Obesity Prescription Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Anti-Obesity Prescription Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Anti-Obesity Prescription Drugs Revenue Share by Players
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Obesity Prescription Drugs by Type (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Obesity Prescription Drugs by Type (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Obesity Prescription Drugs by Region (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Anti-Obesity Prescription Drugs by Region (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share by Application (2012-2017)
Figure China Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table China Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table China Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure Japan Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table Japan Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Japan Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table South Korea Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table South Korea Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure India Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table India Anti-Obesity Prescription Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Figure Australia Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Anti-Obesity Prescription Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Anti-Obesity Prescription Drugs Sales Volume (K Units) by Type (2012-2017)
Table Australia Anti-Obesity Prescription Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Anti-Obesity Prescription Drugs Sales Volume Market Share by Type in 2016
Table Australia Anti-Obesity Prescription Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Australia Anti-Obesity Prescription Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Anti-Obesity Prescription Drugs Sales Volume Market Share by Application in 2016
Table VIVUS Anti-Obesity Prescription Drugs Basic Information List
Table VIVUS Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure VIVUS Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure VIVUS Anti-Obesity Prescription Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure VIVUS Anti-Obesity Prescription Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Basic Information List
Table Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Orexigen Therapeutics Anti-Obesity Prescription Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novo Nordisk Anti-Obesity Prescription Drugs Basic Information List
Table Novo Nordisk Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Anti-Obesity Prescription Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novo Nordisk Anti-Obesity Prescription Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Basic Information List
Table F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure F Hoffmann La Roche Anti-Obesity Prescription Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Prescription Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Prescription Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Prescription Drugs
Figure Anti-Obesity Prescription Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Prescription Drugs Major Manufacturers in 2016
Table Major Buyers of Anti-Obesity Prescription Drugs
Table Distributors/Traders List
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Region in 2022
Figure China Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-Obesity Prescription Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Anti-Obesity Prescription Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Obesity Prescription Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Obesity Prescription Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Anti-Obesity Prescription Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Anti-Obesity Prescription Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Asia-Pacific Anti-Obesity Prescription Drugs Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports